Haemorrhage is a common clinical manifestation in envenomings caused by bites from snakes of the family Viperidae. Therefore, knowing the haemorrhagic potential of venoms and the capacity of antivenoms to neutralise this effect are of paramount relevance in toxinology. The most widely used method for quantifying haemorrhage involves the intradermal injection of venom (or a mixture of venom/antivenom) in mice, and the assessment of the resulting haemorrhagic area in the inner side of the skin. Although this method allows a straightforward assessment of the haemorrhagic activity of a venom, it does not account for haemorrhagic lesions having a similar area but differing in the depth and intensity of haemorrhage. We have developed an approach that allows the assessment of both area and intensity of a venom-induced haemorrhagic lesion using computational tools and propose a unit to represent the combination of these two factors as a measure of haemorrhage intensity, namely haemorrhagic unit (HaU). A strong correlation was observed between haemoglobin extracted from a haemorrhagic lesion and the associated HaUs. The method was used to determine the haemorrhagic activity of the venoms of Bothrops asper, Echis ocellatus and Crotalus basiliscus and the haemorrhage neutralising capabilities of the three associated antivenoms. Overall, the ease of use, as well as the time involved in this new method, makes its implementation very feasible in the determination of haemorrhagic activity of venoms and its neutralisation by antivenoms in the murine model.
Introduction
Snakebite envenomings pose a significant risk to public health globally, especially in tropical and subtropical regions (Chippaux, 1998; Guti errez et al., 2006; Kasturiratne et al., 2008; Warrell, 2010) . It is estimated that five million snakebites per annum occur worldwide, leading to 125,000 deaths (Chippaux, 1998) . Despite its substantial public health threat, snakebite has not received the attention it deserves by the global scientific community and by public health authorities. These aspects, together with the fact that it largely affects impoverished populations in rural communities (Harrison et al., 2009) , makes it a 'neglected tropical disease' (Brown, 2012; Guti errez et al., 2006) .
Currently, the only specific treatment for systemic envenoming is the intravenous administration of antivenom (Brown, 2012; Guti errez et al., 2006; Lalloo and Theakston, 2003; Theakston et al., 2003) . Antivenoms are manufactured by immunizing large animals, usually horses, with snake venoms. Owing to the considerable variation in snake venom composition (Calvete, 2011; Casewell et al., 2014; Chippaux et al., 1991) , the ability of antivenoms to neutralise different snake venoms has to be carefully assessed at the preclinical level . This is particularly relevant when antivenoms raised against the venoms of some snake species are tested against venoms from different species, i.e. heterologous neutralisation.
The gold standard for assessing the preclinical efficacy of antivenoms is based on the neutralisation of lethal effect of venoms in mice (WHO, 2010; Guti errez et al., 2013) . In addition, and owing to the complex pathophysiology of snakebite envenomings, other relevant effects should be tested as well. One such effect is haemorrhage, since many snake venoms, predominantly viperid, induce local and systemic haemorrhage, which is responsible for prominent local tissue damage and cardiovascular disturbances (Warrell, 2010; Escalante et al., 2011) . Thus, the experimental assessment of the haemorrhagic activity of venoms, and its neutralisation by antivenoms, is an important tool in toxinological research.
The most widely used method for analysing haemorrhage is the skin test originally developed in rabbits by Kondo et al. (1960) , and later on adapted for use in rats (Theakston and Reid, 1983 ) and mice (Guti errez et al., 1985) . In the adaptation of this method for mice, a range of different venom concentrations are injected intradermally in the abdominal region. After 2 h, mice are humanely sacrificed and carefully dissected in order to allow the assessment of the inner surface of the skin. Subsequently, the area of the haemorrhagic lesion is measured, and the diameter of the haemorrhagic lesion is estimated. The Minimum Haemorrhagic Dose (MHD) is then determined as the amount of venom that results in a haemorrhagic lesion of 10 mm diameter (Guti errez et al., 1985) . Although this method allows a straightforward assessment of the haemorrhagic activity of venoms, it has limitations. The main drawback of this procedure is that haemorrhagic lesions having a similar diameter might vary in their depth and in the intensity of haemorrhage (De Roodt et al., 2000) . The current methodology does not allow an accurate assessment of these aspects of the haemorrhagic lesions owing to single-variable approach.
The aim of this study was to improve and expand the rodent skin methodology through the application of computational and image analysis tools, allowing a more efficient and accurate analysis of venom induced haemorrhage.
Materials and methods

Snake venoms
Venom of Bothrops asper (batch number 03e06 Bap P) was collected from adult specimens captured in Costa Rica and maintained in captivity at the Serpentarium of Instituto Clodomiro Picado, Universidad de Costa Rica. Venom of Crotalus basiliscus (batch number Cbb-000301) was collected from 15 adult specimens captured in Mexico and maintained in captivity at the Serpentarium of Laboratorios de Biol ogicos y Reactivos de M exico S. A. de C. V. (BIRMEX). Venom of Echis ocellatus (batch number 326.051) from Ghana was obtained from Latoxan. Samples of venom correspond to pools obtained from many specimens, and were stabilized by lyophilisation and stored at À20 C. Solutions of venoms in 0.12 M NaCl, 0.04 M phosphate, pH 7.2 buffer (PBS) were prepared immediately before use.
Antivenoms
The following antivenoms were used: (a) polyvalent antivenom, manufactured by Instituto Clodomiro Picado (batch number 5720416POLQ); it is prepared from the plasma of horses immunized with a mixture of venoms of B. asper, Crotalus simus and Lachesis stenophrys. (b) Polyvalent antivenom, manufactured by BIRMEX, batch number SV-189, using the venoms of B. asper and C. basiliscus for immunization of horses. (c) EchiTab-plus-ICP polyvalent antivenom, manufactured by Instituto Clodomiro Picado (batch number 5750416PALQ), using the venoms of Echis ocellatus, Bitis arietans and Naja nigricollis for immunization of horses.
Description of the new method to quantify haemorrhagic activity
The method describes the use of a free image analysis software (Inkscape 0.91) to determine area and intensity of haemorrhagic lesion. The equipment required for this measurement consists of a camera, a standard colour sheet (Pantone with RGB values with the colours 1895 C, 1905 C, 1915 C, 1925 C and 1935 C) , a ruler and a light box.
Once skin samples are ready to be analysed, the dissected skin of mice is placed over a white A4 paper sheet. Then, the sheet with the skin is introduced in the light box, and the Pantone and ruler are placed next to the samples. Afterwards the light box is sealed, leaving only an opening for the camera (Supplementary file S1). A photograph is taken while ensuring minimal/no surface reflections or varying lighting across the samples.
A detailed description of the methodology described together with an example to illustrate the procedure is shown in Supplementary file S2. An Excel file is included in Supplementary file S3 to facilitate the processing of the data and the estimation of haemorrhagic activity and its neutralisation by this method.
Luminance conversion factor
This step will establish a correction factor using the true R, G and B values shown in the Pantone. Using the software Inkscape 0.91 (https://inkscape.org/download/), the R, G and B values from the standard Pantone sheet (colours 1895 C, 1905 C, 1915 C, 1925 C and 1935 C) are determined. The software shows the values of each colour in terms of red, green and blue (R, G and B values), which should be converted to luminance according to the following equations. The first step involves adjusting the RGB values for the gamma correction and thus transforming these values to sRGB (scaled RGB) values (Pierre et al., 2015; IEC, 2006) . However, since the RGB values are in a value range from 0 to 255, and are required to be in the range from 0 to 1 for further calculations, they need to be divided by 255 (Eq. (1)), where C value is R, G or B values.
If the R, G or B scaled values obtained using equation (1) are higher or equal than 0.04045, the following formula to adjust the R, G or B scaled value should be used (Eq. (2)), where C scaled corresponds to R, G or B scaled values.
On the contrary, if the value is lower than 0.04045, each of the R, G or B scaled values are divided by 12.92 (Eq. (3)) (Pierre et al., 2015; IEC, 2006) , where C scaled is R, G or B scaled values.
Each R, G or B adjusted value is then multiplied by the corresponding conversion factors, according to the luminosity function, which describes the average spectral sensitivity of human visual perception of brightness and states that green light contributes the most to the intensity perceived by humans, and blue light the least. This multiplication will then provide a luminance value for the colour of interest (Eq. (4)) (Pierre et al., 2015; IEC, 2006) .
These steps are applied to all Pantone colours (1905 C, 1915 C, 1925 C and 1935 C) . Once the luminance of all the colours of the Pantone sheet is calculated, the luminance mean value for all the colours analysed is estimated. Subsequently, the real luminance of the Pantone used (calculated from the provided R, G and B values on the Pantone) using equations (1)e(4) (with an estimated value of 0.38958) is divided by the luminance mean value calculated. This value corresponds to the luminance conversion factor (LCF).
Luminance conversion factorðLCFÞ ¼ 0:38958 Luminance mean value (5) Luminance conversion factor corrects the difference between Pantone colours and the existing colour in the image taken by the camera. This procedure has to be carried out for every image taken during the experiments.
Scale conversion factor
Using the tool "Draw Bezier curves and straight lines" of the software Inkscape 0.91, the length of 1 cm on the ruler (included for taking the picture) is determined. Then, the following formula is applied in order to correct for the difference in length between the image and the ruler (Eq. (6)). This calculation has to be carried out for every image taken during the experiments.
Scale conversion factorðSCFÞ ¼ 10
. Quantification of haemorrhage
The intensity of haemorrhagic lesions in the dissected skin of each mice is analysed using the procedure previously described (section 2.3.1). Then, the R, G and B values for each mouse injected with a given amount of venom, or venom/antivenom ratio in the case of neutralisation experiments, is obtained; equations (1)e(4) are applied in order to calculate the luminance (LU; Eq. (4)). Then, the luminance is multiplied by the luminance conversion factor (LCF; Eq. (5)), in order to obtain the true luminance (TL) of the dissected mouse skin (Eq. (7)).
True luminanceðTLÞ ¼ LU Â LCF
The area of the haemorrhagic lesion is then determined using the tool "Draw freehand lines" of the software Inkscape 0.91, and this value is multiplied by the scale conversion factor (Eq. (6)) in order to obtain the real area of the haemorrhagic lesion (Eq. (8)).
Real AreaðRAÞ
Using the values obtained from equations (7) and (8), the haemorrhagic unit (HaU) is calculated according to the following equation (Eq. (9)).
Haemorrhagic Unit ðHaUÞ ¼ RA 10 TL
The haemorrhagic activity of venoms is estimated by plotting the calculated units against the amount of venom, determining the corresponding amount of venom that produces 50 haemorrhagic units (HaU). In the case of antivenom neutralisation tests, the calculated units are plotted against the antivenom/venom ratio used, and the antivenom/venom ratio that reduces the HaU of the challenge dose of venom by 50% is estimated as a quantitative index of neutralisation, corresponding to the Median Effective Dose (ED 50 ).
Comparison between the standard method and image analysis tools
This study meets the International Guiding Principles for Biomedical Research Involving Animals (CIOMS, 1985) . All procedures involving animals were approved by the Institutional Committee for the Care and Use of Laboratory Animals of Universidad de Costa Rica (approval number CICUA 82-08).
Groups of three mice each (18e20 g; CD-1 strain) were injected by the intradermal route with different amounts of Bothrops asper venom (from 1 to 16 mg) dissolved in 100 mL PBS. Two hours after injection, mice were sacrificed by CO 2 inhalation and the haemorrhagic areas were measured using the method described by Guti errez et al. (1985) and using the tool "Draw Bezier curves and straight lines" of the software Inkscape 0.91. The difference between these methods was evaluated by determination of the mean percentage error (MPE) (Eq. (10) 
In another set of experiments, ten mice (18e20 g; CD-1 strain) were injected by the intradermic route with different amounts of B. asper venom (from 1 to 16 mg) dissolved in 100 mL PBS. Two hours after injection, mice were sacrificed by CO 2 inhalation and haemorrhagic units were determined using the method described. Subsequently, haemoglobin content from the haemorrhagic area of each mice injected was assessed following the method described by Rucavado et al. (2000 Rucavado et al. ( , 2002 , with some modifications. A sample of the haemorrhagic lesion on the inner surface of the skin was obtained, placed in a test tube containing 5 mL of Drabkin solution, and left under gentle stirring at 4 C overnight. After this period, the absorbance of the supernatant at 540 nm was recorded and the haemoglobin content determined, using a standard of known concentration, employing the following equation (Eq. (11)).
The equation and Pearson correlation coefficient were estimated by plotting the calculated haemorraghic units against haemoglobin content and analysing these values with Minitab Statistical Software version 16.
Haemorrhagic activity
Haemorrhagic activity was assessed following the method described by Guti errez et al. (1985) with some modifications. Briefly, groups of four mice (18e20 g; CD-1 strain) were injected by the intradermic route with different amounts of either B. asper (1, 2, Haemoglobin contentðg=LÞ ¼ Sample absorbance Â Standard concentration Standard absorbance
4, 8, 16 mg), C. basiliscus (0.5, 1, 2, 4 mg) or E. ocellatus venoms (0.1, 0.2, 1, 2 mg) dissolved in 100 mL PBS. Two hours after injection, mice were sacrificed by CO 2 inhalation to measure the haemorrhagic lesion on the inner surface of the skin, using the method described above (section 2.3) and the standard methodology. The minimum haemorrhagic dose (MHD) was calculated as the amount of venom that induced a haemorrhagic spot with a value of 50 HaU (haemorrhagic units) or a haemorrhagic lesion of 10 mm diameter, respectively. Results were reported as the mean ± SD.
Neutralisation assays
Neutralisation assays were performed using a constant amount of venom ('challenge dose' estimated by image analysis method) and various dilutions of antivenom. Mixtures of venom and antivenom were incubated for 30 min at 37 C (Guti errez et al., 1990 (Guti errez et al., , 1996 . Then, aliquots of the mixtures were tested in the corresponding assays described above. Controls included venom incubated with PBS, without antivenom. Challenge doses of venom for haemorrhagic effect corresponded to 5 MHD for B. asper and E. ocellatus venoms, and 10 MHD for C. basiliscus venom. Neutralisation was expressed as Median Effective Dose (ED 50 ), i.e. the ratio mL antivenom/mg venom that reduced the haemorrhagic units or haemorrhagic diameter of the challenge dose of venom by 50%, respectively. The statistical analysis to compare between values of ED 50 obtained by both methods was accomplished by MannWhitney-U non-parametric analysis (values of P < 0.05 indicated significant difference).
Results and discussion
The purpose of this study was to develop an improved technique for the assessment of venom-induced haemorrhage in mice. The implementation of a combination of photographic and computational tools enabled us not only to make the existing method more efficient, but also to make it more precise in terms of assessing the intensity of the haemorrhagic lesions. We developed a fast and accurate technique that for the first time allows the assessment of local haemorrhage, using area as well as the novel addition of intensity. This method solves the problem of the classical method based on the measurement of the area of haemorrhage, which does not take into account for the intensity of the haemorrhagic area, i.e. the actual extent of haemorrhage.
Comparing the determination of haemorrhagic area between the standard method and the image analysis approach
The method most commonly used for the assessment of venominduced haemorrhage in mice requires the manual assessment of a haemorrhagic lesion's area through the use of tracing and graph paper (Guti errez et al., 1985) . This method is time consuming and introduces inaccuracies, since the final stage requires a visual estimation of square millimetres encompassed by the haemorrhagic lesion. However, due to the inconsistent lesion shapes, the probability of human error is high. Interestingly, in the case of B. asper venom, when using this method the mean percentage error of the classical approach is higher at lower venom doses (Table 1) . Fig. 1A and B shows different haemorrhagic lesions caused by various doses of B. asper venom, where the irregular shape of the lesions is evident. Therefore, even if the intensity of the haemorrhagic lesion is not considered, the use of a photographic and computational approach is recommended to determine the areas of haemorrhage with enhanced accuracy.
Assessment of the new method which considers both area and intensity of haemorrhage
In addition to the accuracy in the measurement of haemorrhagic area, it is important to consider the intensity of the lesion. Fig. 1 shows that, for the venom of B. asper, similar areas of haemorrhage present different intensities of haemorrhage, and this needs to be considered in the quantitative estimation of haemorrhagic activity of venoms. To this end, a new methodology was developed. To ensure the validity of this methodology, which takes into consideration both the area and the intensity of the haemorrhagic lesions, we studied the correlation between the amount of haemoglobin in the skin and the determination of haemorrhagic units with the new method. The amount of haemoglobin found in haemorrhagic lesions has been used as an index of haemorrhage intensity, since the amount of haemoglobin in the tissue is directly related to the number of erythrocytes, i.e. with the extent of haemorrhage (Ownby et al., 1984; Rucavado et al., 2002) . However, since this method is time consuming and thus hard to apply as standard practice, we decided to assess the correlation between haemoglobin and our newly defined haemorrhagic units to further validate our method. A strong linear relationship between haemorrhagic units (HaU) and haemoglobin (g/L) was observed, underscoring a distinct correlation between the two (Fig. 2) .
Defining haemorrhagic activity for three different venoms
After ensuring that our method shows a strong correlation with haemoglobin present in the tissue due to venom inoculation, we determined the minimum haemorrhagic dose based on the standard (10 mm diameter lesion) and proposed method (50 HaU) for the venom of three species of venomous snakes known to cause prominent localised haemorrhage, i.e. B. asper, C. basiliscus and E. ocellatus (Table 2) . When the estimated MHDs of the three venoms are compared and expressed, for each method, as the ratio of MHD of E. ocellatus: C. basiliscus: B. asper, results indicate that, for the classical method the ratio is 1.0: 7.8: 8.6, whereas when the new method is used, this ratio is 1.0: 16.6: 45.6. Thus, although qualitatively both methods indicate that the order of haemorrhagic activity of the venoms is E. ocellatus > C. basiliscus > B. asper, there are significant quantitative differences between them. For example, the classical method indicates that E. ocellatus venom is only 8.6 times more haemorrhagic than B. asper venom, whereas the new method indicates that it is 45.6 times more active. This large difference between methods has to do precisely with the different intensity of the haemorrhagic areas, as the venom of E. ocellatus induces more intense haemorrhagic lesions than the venom of B. asper. Since the new method assesses intensity, and this is directly proportional to the amount of haemoglobin in the tissue, it is evident that it better reflects haemorrhagic activity from a quantitative standpoint. 10.9 ± 3.6 9.8 ± 4.1 12 4
11.6 ± 0.3 10.9 ± 0.3 6 8 13.8 ± 0.4 13.1 ± 0.8 5 16
17.2 ± 0.5 16.6 ± 0.5 4 a Area was determined using three mice per venom concentration.
Assessing the neutralising ability of antivenoms for three different venoms
Using both methods, we tested the neutralising ability of antivenoms, which was expressed as the Median Effective Dose (ED 50 ), based on the MHD values obtained with the new method for B. asper, C. basiliscus, and E. ocellatus venoms. As depicted in Table 3 , relatively similar values of ED 50 s were obtained for these antivenoms when using the two methods. Based on the fact that neutralisation is expressed relatively to the action of venom incubated with no antivenom (100% activity), these results are expected, since neutralisation of haemorrhagic activity would be reflected as reduction in both haemorrhagic area and intensity of the haemorrhagic lesion. Thus, the advantage of the new method in the study of neutralisation by antivenoms is based on the convenience and accuracy of the assay, not on the fact that it gives very different results as compared with the classic method. Arias et al. (2017) , which used the same venom batch as the one used in this study.
Sources of error and future improvements
Despite the advantages of our novel approach and the range of control measures implemented, there are still some limitations that need to be considered for improving it. The main risk of error applies to the stage of averaging the RGB values within the haemorrhagic area in Inkscape. It is at the user's discretion to define a representative area for the colouring within the haemorrhagic lesion, which can cause some discrepancies. This can be improved by establishing the conditions in which the program determines the area of the haemorrhagic lesion by image analysis. It is important to remark the need of using a light box in order to avoid the effect of light reflections on the haemorrhagic surface area which can skew the readings. The use of alternative software to estimate the intensity and area of haemorrhagic lesions is possible, as long as the methodology hereby described is followed.
Conclusions
We have developed a new method that allows a two-factor assessment of venom induced haemorrhagic lesions by taking both area and intensity into account. The use of free open source software and other commonly available resources ensures minimal cost for the application of this method. Furthermore, together with its ease of use, it makes the implementation of this novel approach on a global scale very feasible. This in turn will greatly improve the precision of determining MHD and minimise human error, without much effort. It has also the potential to aid in the assessment of the neutralising capabilities of antivenoms; however, it should be considered that the findings are based on a murine model and thus extrapolations to the clinical situation have to be made with caution. In the future, there is also a potential for further improvements, such as an application that only requires an input picture of a haemorrhagic lesion and that can then automatically compute the required outputs, e.g. MHD of a venom of interest, which would make the method even more accessible and globally realisable. A similar methodology could be used for the analysis of other types of venom-induced lesions in the skin of mice, such as dermonecrotic lesions, for which the method described can be adapted. Table 3 Determination of neutralising activity of specific antivenoms towards the haemorrhagic activity using the standard method and proposed image analysis method.
Venom
Antivenom Standard method (mL AV/mg V)
Image analysis method (mL AV/mg V)
Bothrops asper ICP 109 ± 20 65 ± 9 Crotalus basiliscus BIRMEX 138 ± 2 158 ± 35 Echis ocellatus EchiTab þ ICP 630 ± 4 663 ± 10 ED 50 corresponds to the ratio mL antivenom/mg venom, which reduced the haemorrhagic lesion of the challenge dose of venom by 50%. Results are presented as mean ± S.D. (n ¼ 4). These determinations were carried out using the MHD for each venom, as determined with the image analysis method. No statistical differences were found between methods (P > 0.05, Mann Whitney-U test).
